Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Life Sci ; 239: 117014, 2019 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-31678278

RESUMO

AIMS: Previous studies have demonstrated that epigallocatechin gallate (EGCG) had certain protective effects on myocardial and renal ischemia reperfusion (I/R) injury. We aimed to research the special effects and underling mechanisms of EGCG on skeletal muscle I/R injury. MAIN METHOD: We established an experimental rat model of I/R skeletal muscle injury and treated with different doses of EGCG. Hematoxylin eosin staining, TUNEL assay, ELISA, qRT-PCR and Western blotting were used to evaluate the effects of EGCG. KEY FINDINDS: EGCG significantly improved skeletal muscle function of I/R injury rats. Moreover, EGCG had positive effects on decreasing apoptosis of skeletal muscle tissues, alleviating oxidative stress damage and suppressing the production of inflammatory cytokines. Further, EGCG had positive effects on activating Nrf2/HO-1 signaling pathway. SIGNIFICANCE: EGCG might be a powerful candidate compound for alleviating I/R injury in rat skeletal muscle.


Assuntos
Antioxidantes/uso terapêutico , Catequina/análogos & derivados , Heme Oxigenase (Desciclizante)/efeitos dos fármacos , Músculo Esquelético/irrigação sanguínea , Fator 2 Relacionado a NF-E2/efeitos dos fármacos , Traumatismo por Reperfusão/tratamento farmacológico , Ativação Metabólica/efeitos dos fármacos , Animais , Apoptose/efeitos dos fármacos , Catequina/uso terapêutico , Citocinas/biossíntese , Masculino , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...